anonymous
Guest
anonymous
Guest
n a letter to Allergan CEO Brent Saunders Tuesday, Sens. Sherrod Brown , D-Ohio; Maggie Hassan, D-N.H.; Amy Klobuchar , D-Minn.; Al Franken , D-Minn., and Patty Murray , D-Wash., requested documents and information about the deal, calling it a "blatant attempt to further Allergan's market monopoly" on its $1.5 billion eye drug, Restasis. "It is difficult to conceive of Allergan's transaction as anything other than a sham to subvert the existing intellectual property system," the senators wrote